Functional and motor gastrointestinal disorders

Antonia Perello Juan

  • Carles Pons Vilardell
  • Merce Barenys De Lacha
  • Natalia Carrasco Fons
  • Joana Villaverde Haro
  • Ana Belen Vega Lopez
  • Beatriz Garcia Zafra
  • Dolores Osuna Fernandez
  • Lourdes Martos Garcia
  • Diana Kaptoul Pique
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention

Scientific production





Selected publicationss

  • Calafat, Margalida; Manosa, Miriam; Canete, Fiorella; Ricart, Elena; Iglesias, Eva; [53 authors]; Van Domselaar, Manuel; Vela, Milagros; Velayos, Benito; Verdejo, Cristina; Huguet, Jose M.;ENEIDA Registry GETECCU. Increased risk of thiopurine-related adverse events in elderly patients with IBD. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 10.1111/apt.15458
  • Serrano-Falcón B., Delgado-Aros S., Mearin F., Ciriza de los Ríos C., Serra J., Mínguez M., Montoro Huguet M., Perelló A., Santander C., Pérez Aisa Á., Bañón-Rodríguez I., Rey E.. Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 10.1177/1756284819857358
  • Sabé N., Oriol I., Melilli E., Manonelles A., Bestard O., Polo C., Arcos I.L., Perelló M., Garcia D., Riera L., Tebé C., Len O., Moreso F., Cruzado J.M., Carratalà J.. Antibiotic treatment versus no treatment for asymptomatic bacteriuria in kidney transplant recipients: A multicenter randomized trial. OPEN FORUM INFECTIOUS DISEASES. 10.1093/ofid/ofz243
  • Mearina, Fermin; Caballero, Antonio M.; Serra, Jordi; Brotons, Cartes; Tantina, Ana; Fort, Esther; Martinez-Cerezo, Francisco J.; Perello, Antonia; Sanchez-Antolin, Gloria; Rey, Enrique; Angos Musgo, Ramon; Berdier, Ruth; Gomez-Rodriguez, Blas; Clave, Pere; Garcia-Alonso, Monica; Toran-Monserrat, Pere; Tack, Jan;. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. GASTROENTEROLOGIA Y HEPATOLOGIA. 10.1016/j.gastrohep.2018.10.008

Research highlights


4 Ongoing clinical trials

4 Started clinical trials

Selected projects

  • Phase 3, multicenter, randomized, double-blind, placebo-controlled study of oral Ozanimod as maintenance therapy for moderately t severely active crohn’s DISEASE (24/1/2019 – ) PI: PERELLó JUAN, ANTONIA. Funder ref.: RPC01-3203.
  • Phase 3, multicenter, randomized, double-blind, placebo-controlled study of oral Ozanimod as induction therapy for moderately to severely active crohn’s disease (24/1/2019 – ) PI: PERELLó JUAN, ANTONIA. Funder ref.: RPC01-3201.
  • Phase II, multicentre, randomised, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX 600 mg tablets administered tree or two times daily to patients with diarrhoea-predominant irritable vowel syndrome (IBS-D) (27/9/2019 – ) PI: PERELLó JUAN, ANTONIA. Funder ref.: CB-01-11/28